Grassley Probes FDA Contractor’s Posting Of Confidential Documents
This article was originally published in The Tan Sheet
Executive Summary
The ranking member of the Judiciary Committee said “thousands of pages of NIH grant information, including internal emails and documents, were easily accessible online” through Quality Associates’ site.” He also asked why internal documents were available publicly and searchable on search engines.
You may also be interested in...
FDA Email Surveillance Generates Court Battle And Image Problem
FDA’s biggest battle could be in the court of public opinion as employees claim the agency targeted and suppressed them based on their viewpoints and conducted intrusive searches and seizures. FDA says the surveillance began after a device industry attorney complained that a firm’s confidential information had been released.
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.
Current Pathways For Rare Disease Drugs Are Not Optimal, US FDA’s Califf Says
Anticipating a ‘tsunami of therapies’ for rare diseases, commissioner says the agency will have to think of creative approaches and employ regulatory flexibility for them. FDA considers copying the oncology center’s Project Facilitate for expanded access to other diseases.